Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Xeris Biopharma Holdings Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
XERS
Nasdaq
8731
https://www.xerispharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Xeris Biopharma Holdings Inc
Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges
- May 10th, 2024 7:21 pm
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
- May 10th, 2024 4:36 pm
Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations
- May 10th, 2024 12:23 pm
Q1 2024 Xeris Biopharma Holdings Inc Earnings Call
- May 10th, 2024 4:27 am
Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates
- May 9th, 2024 12:10 pm
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
- May 9th, 2024 11:00 am
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
- May 6th, 2024 11:01 am
Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock
- May 2nd, 2024 3:24 pm
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
- May 2nd, 2024 11:00 am
Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
- Apr 17th, 2024 11:24 am
Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions
- Apr 5th, 2024 3:15 pm
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Apr 3rd, 2024 8:05 pm
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Apr 2nd, 2024 11:00 am
Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results
- Mar 9th, 2024 2:14 pm
Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023
- Mar 7th, 2024 6:47 pm
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 4:56 pm
Q4 2023 Xeris Biopharma Holdings Inc Earnings Call
- Mar 7th, 2024 4:16 am
Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
- Mar 6th, 2024 1:15 pm
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
- Mar 6th, 2024 12:02 pm
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
- Mar 6th, 2024 12:00 pm
Scroll